Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning (Q40202824)
Jump to navigation
Jump to search
scientific article published on 29 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning |
scientific article published on 29 November 2006 |
Statements
1 reference
Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning (English)
1 reference
Stellan Sandler
1 reference
Robert Hägerkvist
1 reference
Dariush Mokhtari
1 reference
Nils Welsh
1 reference
29 November 2006
1 reference
1 reference
21
1 reference
2
1 reference
618-628
1 reference
Identifiers
1 reference
1 reference